do medicare advantage plans cover glp 1 drugs CMS Issues Coverage Guidance on GLP-1 Anti-Obesity Access to GLP-1 weight loss

Even if you were on high-dose tirzepatide, the semaglutide-specific side effect profile requires independent titration

This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 12 digital issues and online access to articles 135,68 per year only 11,31 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF

Conflict of interest statement Within the last 36 months, FK has served on scientific advisory panels and/or been part of speaker's bureaus for, served as a consultant to and/or received research support from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Gubra, MedImmune, MSD/Merck, Mundipharma, Norgine, Novo Nordisk, Sanofi and Zealand Pharma

doi: 10.2337/diacare.27.11.2628 [DOI] [PubMed] [Google Scholar] 53

Side effects with current GLP-1 drugs are attributed to the triggering of alternative pathways